WHO Applauds Iran’s Dedication to Fighting Hepatitis: A Model for Global Health
On World Hepatitis Day, Jaffar Hussain, the World Health Organization (WHO) Representative to Iran, praised the efforts of Iranian health experts, officials, and citizens in tackling hepatitis B and C. His recognition highlights the nation’s **commitment to eliminate hepatitis**, acknowledging that while viral hepatitis remains one of the leading causes of death globally, it is both preventable and curable.
World Hepatitis Day, observed every year on July 2, serves as a reminder of the importance of raising public awareness and renewing commitments to combat this health crisis. Hussain emphasized that the eradication of hepatitis requires collective measures and widespread participation from all sectors of society, according to a report by IRNA.
In his remarks, Hussain pointed out Iran’s significant achievements in managing hepatitis B, particularly through vaccination programs. However, he also noted the ongoing challenges, especially regarding hepatitis C among vulnerable populations. He stated, “We need to focus on health quality and programs such as peer support, harm reduction services, and the expansion of tests and treatments.”
Hussain advocated for the integration of hepatitis services with Primary Health Care (PHC) as a strategic approach. He believes this integration will lead to:
- Improved access to healthcare services
- Enhanced delivery of services
- Stronger community engagement
- Better health outcomes
- Sustainable financing
He further emphasized that eradicating hepatitis is not only a health goal but also a step toward achieving justice, human dignity, and equality. This underscores the importance of investing in stigma-free, patient-centered care.
Iran’s Commitment to Hepatitis C Eradication
The Iranian health ministry has set ambitious goals to eliminate hepatitis C by the Iranian year 1405 (March 2026 – March 2027). Deputy Health Minister Alireza Raeisi confirmed that this will be achieved through meticulous planning and the broad participation of various sectors. He stated, “The country will continue to implement diagnostic, therapeutic, and preventive policies to achieve international recognition in the eradication of hepatitis C.”
Raeisi made these remarks during a global webinar for World Hepatitis Day 2025, attended by WHO representatives and other international organizations. He pointed out that Iran has successfully managed diseases like malaria and tuberculosis, even with its borders shared with Afghanistan and Pakistan, where infectious diseases are more prevalent.
Fortunately, Iran has executed effective vaccination programs, ensured injection safety, conducted blood screenings, and prevented mother-to-child transmission of hepatitis. Raeisi outlined a strategic plan in phases, aiming for:
- **Bronze Medal**: Identifying 60% of infected individuals and treating 40% of them by March 2026. Approximately 13,000 to 21,000 people are diagnosed annually.
- **Silver Medal**: Diagnosing 70% of individuals with hepatitis and curing 60% of them.
- **Gold Medal**: Treating 70-80% of people diagnosed with hepatitis.
Raeisi stressed that the elimination of hepatitis is not just a slogan but a national commitment. The national hepatitis elimination program focuses on actively identifying cases among high-risk groups, including drug users, prisoners, patients with rare diseases, and refugees. The program also emphasizes providing free treatment and public insurance coverage.
Amidst challenges such as sanctions, Raeisi called upon the WHO and UNICEF to bolster their support for Iran in achieving its health objectives. He expressed gratitude for their ongoing assistance in supplying essential equipment, sharing knowledge, and reducing harm in high-risk populations.
Hepatitis is caused by various infectious viruses and non-infectious agents, leading to serious health complications that can be fatal. A critical gap in addressing this issue is the **low coverage of testing and treatment**, which must be improved to meet the global elimination targets set for 2030.
In conclusion, the commitment of Iran to eradicate hepatitis C through comprehensive strategies and community involvement showcases a proactive approach to public health challenges. This determination not only aims to improve health outcomes but also strives for social equity and justice in healthcare.
